Mahran Shoukier
Hematology
2130 W Holcombe Blvd Fl 10
Houston, TX 77030
Houston, TX 77030
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Industry's role in HIV, hepatitis B, and hepatitis C exclusion in AML and MDS clinical trials.
Journal: Hematology (Amsterdam, Netherlands)
Published: September 08, 2023
Treatment patterns and outcomes of high-grade immune checkpoint inhibitor-related pneumonitis in an oncology hospitalist service.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: July 25, 2023
Representation of the population in need for pivotal clinical trials in lymphomas.
Journal: Blood
Published: February 09, 2023
A Phase I Study of the Non-Receptor Kinase Inhibitor Bosutinib in Combination with Pemetrexed in Patients with Selected Metastatic Solid Tumors.
Journal: Current oncology (Toronto, Ont.)
Published: October 26, 2022
Are Pivotal Clinical Trials for Drugs Approved for Leukemias and Multiple Myeloma Representative of the Population at Risk?
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 09, 2022
Activity of decitabine as maintenance therapy in core binding factor acute myeloid leukemia.
Journal: American journal of hematology
Published: December 16, 2021
Sudden Blast Crisis After Excellent Initial Response in Chronic Myeloid Leukemia.
Journal: Cureus
Published: September 28, 2021
Review of New-Generation Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia.
Journal: Current oncology reports
Published: April 30, 2021
Post-transplantation cyclophosphamide reduces the incidence of acute graft-versus-host disease in patients with acute myeloid leukemia/myelodysplastic syndromes who receive immune checkpoint inhibitors after allogeneic hematopoietic stem cell transplantation.
Journal: Journal for immunotherapy of cancer
Published: January 26, 2021
The effect of eltrombopag in managing thrombocytopenia associated with tyrosine kinase therapy in patients with chronic myeloid leukemia and myelofibrosis.
Journal: Haematologica
Published: September 10, 2020
Last Updated: 09/26/2026